TMPRSS2–ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry

To study prostate cancer zonal differences in TMPRSS2–ERG gene rearrangement.

[1]  G. Sauter,et al.  High level of Ets‐related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers , 2012, Histopathology.

[2]  G. Kristiansen,et al.  ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies , 2012, Prostate Cancer and Prostatic Diseases.

[3]  A. Partin,et al.  Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas , 2011, Modern Pathology.

[4]  M. Rubin,et al.  Iconografías adicionales del artículo : TMPRSS2-ERG Fusion Heterogeneity in Multifocal Prostate Cancer: Clinical and Biologic Implications , 2011 .

[5]  T. Tsuzuki,et al.  ERG gene rearrangement status in prostate cancer detected by immunohistochemistry , 2011, Virchows Archiv.

[6]  J. Hicks,et al.  Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas , 2011, The American journal of surgical pathology.

[7]  M. Rubin,et al.  Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer , 2011, Histopathology.

[8]  J. Squire,et al.  Detection of ERG gene rearrangements and PTEN deletions in unsuspected prostate cancer of the transition zone , 2011, Cancer biology & therapy.

[9]  M. Rubin,et al.  Single focus prostate cancer: pathological features and ERG fusion status. , 2011, The Journal of urology.

[10]  Jaya M Satagopan,et al.  TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features , 2010, Modern Pathology.

[11]  M. Rubin,et al.  ERG rearrangement is present in a subset of transition zone prostatic tumors , 2010, Modern Pathology.

[12]  K. Trpkov,et al.  TMPRSS2-ERG gene fusion in transition zone prostate cancer , 2010, Modern Pathology.

[13]  S. Varambally,et al.  Antibody-based detection of ERG rearrangement-positive prostate cancer. , 2010, Neoplasia.

[14]  S. Srivastava,et al.  ERG Expression Levels in Prostate Tumors Reflect Functional Status of the Androgen Receptor (AR) as a Consequence of Fusion of ERG with AR Regulated Gene Promoters , 2010 .

[15]  P. Scardino,et al.  Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors. , 2009, The Journal of urology.

[16]  Arul M Chinnaiyan,et al.  Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States , 2009, Clinical Cancer Research.

[17]  B. Czerniak,et al.  Prostate cancer of transition zone origin lacks TMPRSS2–ERG gene fusion , 2009, Modern Pathology.

[18]  W. Gerald,et al.  TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. , 2009, Cancer research.

[19]  C. LaFargue,et al.  TMPRSS2-ERG fusion is frequently observed in gleason pattern 3 prostate cancer in a Canadian cohort , 2009, Cancer biology & therapy.

[20]  P. Scardino,et al.  Do Prostatic Transition Zone Tumors Have a Distinct Morphology? , 2008, The American journal of surgical pathology.

[21]  P. Scardino,et al.  Anterior-predominant Prostatic Tumors: Zone of Origin and Pathologic Outcomes at Radical Prostatectomy , 2008, The American journal of surgical pathology.

[22]  J Cuzick,et al.  Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer , 2008, Oncogene.

[23]  P. Scardino,et al.  Anatomy of the Anterior Prostate and Extraprostatic Space: A Contemporary Surgical Pathology Analysis , 2007, Advances in anatomic pathology.

[24]  J. Trachtenberg,et al.  Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer , 2007, British Journal of Cancer.

[25]  R. Shah,et al.  Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. , 2007, Cancer research.

[26]  Yao-Tseng Chen,et al.  Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues , 2007, Modern Pathology.

[27]  Y Pawitan,et al.  TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort , 2007, Oncogene.

[28]  S. Leung,et al.  Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers , 2007, Journal of Clinical Pathology.

[29]  M. Rubin,et al.  TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion , 2006, The American journal of surgical pathology.

[30]  N. Ragavan,et al.  Gene expression profiling of the human prostate zones , 2006, BJU international.

[31]  Michael Ittmann,et al.  Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. , 2006, Cancer research.

[32]  J. Tchinda,et al.  TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.

[33]  I. Panagopoulos,et al.  Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. , 2006, Genes, chromosomes & cancer.

[34]  I. Panagopoulos,et al.  Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer , 2006 .

[35]  V. Srikantan,et al.  Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2006, Oncogene.

[36]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[37]  Rile Li,et al.  Neuroanatomy of the normal prostate , 2005, The Prostate.

[38]  V. Srikantan,et al.  Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2005, Oncogene.

[39]  R. Cohen,et al.  Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour , 2003, Pathology.

[40]  M. Kattan,et al.  Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. , 2003, Radiology.

[41]  S. Bott,et al.  Anterior prostate cancer: is it more difficult to diagnose? , 2002, BJU international.

[42]  T. Stamey,et al.  An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.

[43]  J. McNeal.  Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. , 1992, Human pathology.

[44]  P. Scardino,et al.  Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis. , 1991, British journal of urology.

[45]  P. Scardino,et al.  A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. , 1991, The Journal of urology.

[46]  M. Terris,et al.  Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. , 1991, The Journal of urology.

[47]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[48]  J. McNeal,et al.  Normal histology of the prostate. , 1988, The American journal of surgical pathology.

[49]  Dr. M. Roth.  Ein Fall von Retinitis leukaemica , 1870, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[50]  E. Noel,et al.  Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland , 2008, Prostate Cancer and Prostatic Diseases.

[51]  M. Graefen,et al.  Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone. , 2002, European urology.

[52]  M. Leversha.  Mapping of genomic clones by fluorescence in situ hybridization. , 2001, Methods in molecular biology.

[53]  P. Scardino,et al.  Anatomy of the prostate and distribution of early prostate cancer. , 1995, Seminars in surgical oncology.

[54]  D. Grignon,et al.  Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? , 1994, Journal of cellular biochemistry. Supplement.